Trupanion Inc. logo

Trupanion Inc. (TRUP)

Market Closed
12 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
36. 36
-0.14
-0.38%
$
1.52B Market Cap
- P/E Ratio
0% Div Yield
216,707 Volume
-1.22 Eps
$ 36.5
Previous Close
Day Range
36.19 36.85
Year Range
31 57.88
Want to track TRUP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 60 days
Here's Why You Should Stay Invested in Trupanion (TRUP) Stock

Here's Why You Should Stay Invested in Trupanion (TRUP) Stock

Trupanion Inc. TRUP is set to benefit from its focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position. These, along with solid growth projections, make the stock worth retaining.

Zacks | 1 year ago
Should You Retain Trupanion (TRUP) Stock in Your Portfolio?

Should You Retain Trupanion (TRUP) Stock in Your Portfolio?

Trupanion (TRUP) gains from a focus on pet health and well-being in the pet insurance market. Its solid balance sheet supports investment in new product development and international expansion.

Zacks | 1 year ago
Trupanion: Growth First, Profitability Second

Trupanion: Growth First, Profitability Second

Trupanion is a global pet insurance company. Trupanion may be headed for profitability, with the new CEO emphasizing efficiency and free cash flow. The company offers pet insurance through subscriptions, focusing on growth first and profits later.

Seekingalpha | 1 year ago
Trupanion (TRUP) Rallies 27% in a Year: More Upside Left?

Trupanion (TRUP) Rallies 27% in a Year: More Upside Left?

Focus on pet health and well-being in an underpenetrated pet insurance market, product launches, extended operating boundaries and a solid capital position continue to drive Trupanion (TRUP).

Zacks | 1 year ago
Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by Amalgamated Bank

Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by Amalgamated Bank

Amalgamated Bank decreased its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,952 shares of the financial services provider’s stock after selling 397 shares during the period. Amalgamated Bank’s holdings in Trupanion were worth $487,000 at the end of the most recent reporting period. Other large investors have also modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Trupanion by 35.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,011 shares of the financial services provider’s stock valued at $254,000 after acquiring an additional 2,367 shares during the period. Nisa Investment Advisors LLC lifted its stake in shares of Trupanion by 108.9% in the third quarter. Nisa Investment Advisors LLC now owns 18,930 shares of the financial services provider’s stock valued at $534,000 after purchasing an additional 9,869 shares during the period. Check Capital Management Inc. CA boosted its holdings in Trupanion by 32.1% during the third quarter. Check Capital Management Inc. CA now owns 22,925 shares of the financial services provider’s stock worth $646,000 after buying an additional 5,575 shares in the last quarter. Versor Investments LP acquired a new position in Trupanion during the third quarter worth about $391,000. Finally, New York State Common Retirement Fund increased its holdings in Trupanion by 1.4% in the third quarter. New York State Common Retirement Fund now owns 79,142 shares of the financial services provider’s stock valued at $2,232,000 after buying an additional 1,101 shares in the last quarter. Trupanion Trading Down 7.9 % Trupanion stock opened at $30.24 on Monday. The stock has a market cap of $1.27 billion, a PE ratio of -47.25 and a beta of 1.76. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.42. The stock has a 50-day moving average price of $25.56 and a 200 day moving average price of $27.13. Trupanion, Inc. has a 52 week low of $18.45 and a 52 week high of $36.66. Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.02. The business had revenue of $306.12 million during the quarter, compared to the consensus estimate of $300.51 million. Trupanion had a negative net margin of 2.31% and a negative return on equity of 9.03%. The company’s quarterly revenue was up 19.4% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.60) earnings per share. Equities research analysts predict that Trupanion, Inc. will post -0.48 earnings per share for the current fiscal year. Wall Street Analysts Forecast Growth A number of equities research analysts recently weighed in on TRUP shares. Evercore ISI lowered their price target on Trupanion from $35.00 to $31.00 and set an “outperform” rating on the stock in a report on Tuesday, February 20th. Bank of America upgraded Trupanion from a “neutral” rating to a “buy” rating and raised their price target for the company from $35.00 to $49.00 in a research report on Thursday. Piper Sandler decreased their price objective on shares of Trupanion from $28.00 to $22.00 and set a “neutral” rating on the stock in a research report on Friday, May 3rd. Canaccord Genuity Group dropped their target price on shares of Trupanion from $40.00 to $34.00 and set a “buy” rating for the company in a report on Friday, May 3rd. Finally, Stifel Nicolaus upped their price target on shares of Trupanion from $25.00 to $28.00 and gave the company a “hold” rating in a report on Friday, February 16th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $32.80. Read Our Latest Research Report on Trupanion Insider Buying and Selling at Trupanion In other news, SVP Emily Dreyer sold 3,125 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $25.34, for a total transaction of $79,187.50. Following the sale, the senior vice president now owns 19,830 shares in the company, valued at $502,492.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Darryl Rawlings acquired 20,700 shares of the company’s stock in a transaction dated Tuesday, May 7th. The stock was bought at an average price of $24.14 per share, with a total value of $499,698.00. Following the purchase, the chief executive officer now directly owns 614,842 shares in the company, valued at approximately $14,842,285.88. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Emily Dreyer sold 3,125 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $25.34, for a total transaction of $79,187.50. Following the completion of the sale, the senior vice president now directly owns 19,830 shares in the company, valued at $502,492.20. The disclosure for this sale can be found here. 5.81% of the stock is currently owned by insiders. Trupanion Company Profile (Free Report) Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Defenseworld | 1 year ago